| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.4 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |